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HIGHLIGHTS 
 Many substance misusers who also smoke are motivated to quit but lack 
support.  
 Professionals require training and resources to support smoking cessation. 
 Provision of smoking cessation support when smoking bans are in place is key. 
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 Development of interventions targeting the unique needs of this group is 
needed. 
 
ABSTRACT 
Introduction: Smoking prevalence among those in substance misuse treatment 
remains much higher than the general population, despite evidence for effective 
cessation interventions that do not negatively impact substance misuse outcomes. 
This systematic review summarises qualitative data on barriers and facilitators to 
smoking cessation for people in substance misuse treatment, participants’ and 
providers’ perceptions about effects of smoking cessation on substance misuse 
treatment, timing of intervention delivery and aspects of interventions perceived to be 
effective.  
Methods: Systematic review of qualitative studies and thematic synthesis of published 
qualitative data.  
Results: 10939 records and 132 full texts were screened. 22 papers reporting on 21 
studies were included. Key themes identified were: strong relationships between 
smoking and other substance misuse; environmental influences; motivation; mental 
health; aspects of interventions perceived to be effective/ineffective; barriers and 
facilitators to intervention implementation; smoking bans/restrictions; and relationships 
with professionals. Many service users were motivated toward smoking cessation but 
were not offered support. Some felt interventions should be delivered after substance 
misuse treatment, whilst others felt concurrent/dual interventions would be beneficial, 
due to strong associations between smoking and other substances. Treatment 
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providers felt they lacked training and resources for supporting smoking cessation, 
and were concerned about impact on substance misuse outcomes.  
Conclusions: Many substance misusers who also smoke are motivated to quit but 
perceive a lack of support from professionals. Additional training and resources are 
required to enable professionals to provide the support needed. More research is 
required to develop enhanced packages of care for this deprived group of smokers. 
 
Key words: Smoking cessation; substance misuse; systematic review; 
qualitative 
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1. INTRODUCTION 
Smoking prevalence amongst those in substance misuse treatment is much higher 
than the general population. In the United Kingdom (UK), United States of America 
(USA), Australia, Canada and Switzerland, estimates of smoking prevalence in this 
group range from 77% to 98% (1-10), whilst smoking prevalence in the general 
population is estimated at 15.5% in England in 2016 (11), 15.1% in the USA in 2015 
(12), 17.7% in Canada in 2015 (13) and 14.7% in Australia 2014-15 (14). According 
to a 2014 survey of people in residential addiction services in London, UK, among the 
88% of respondents who were current smokers, 79% expressed a desire to quit but 
56% had never been offered support for smoking cessation and only 15% had been 
offered support during their current treatment episode (10).  
 
Smoking causes considerable morbidity and mortality among substance misusers. 
Hser et al. (6) found that the death rate among substance misusers who concurrently 
smoked was four times higher than non-smoker substance misusers. Hurt et al. (15) 
found that in a population who had received inpatient treatment for substance misuse, 
tobacco-related diseases were the leading cause of death. There are a wide variety of 
smoking cessation methods (16-18) but no specific National Institute for Health and 
Care Excellence (NICE) guidance on smoking cessation for people in substance 
misuse treatment/recovery (19-21) and no obvious theoretical framework upon which 
to base intervention development.  
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A meta-analysis of 19 randomised controlled trials (RCTs) of smoking cessation 
interventions for people in substance misuse treatment/recovery found interventions 
were effective in the short term and associated with a 25% increased likelihood of long 
term abstinence of other substance misuse, although evidence of intervention 
effectiveness for smoking cessation in the long term was limited (22). A more recent 
systematic review of 17 studies found some evidence for the effectiveness of nicotine 
replacement therapy (NRT), behavioural support and combination approaches, and 
some evidence of improved substance misuse outcomes (18).  
 
A previous systematic review of qualitative and quantitative (i.e. longitudinal, cross-
sectional or cohort surveys) studies has been conducted, with wide inclusion criteria, 
assessing barriers to smoking cessation across vulnerable groups (23). This previous 
review included just one qualitative study of substance misusers who were homeless. 
The review identified common barriers among this group of substance misusers, and 
the other vulnerable groups studied. Barriers included smoking for stress 
management, lack of support from service providers and high prevalence and 
acceptability of smoking. Similarly, a previous mixed-methods systematic review of 
mental health professionals’ attitudes towards smoking cessation among their clients 
has been conducted (24). Although this review included those working with substance 
misusers, results for this group were not separately analysed.  
 
This systematic review aims to extend and enhance the findings of existing reviews 
(18, 22-25) by providing a context for interpreting and explaining the results of the 
quantitative syntheses on barriers and facilitators for smoking cessation, in the specific 
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context of substance misuse services. A qualitative synthesis aims to go beyond small, 
context specific studies to attempt to draw broader, more transferable lessons from 
the data.  
The protocol was registered and published in PROSPERO (26). Review questions 
were: 
 What are the reported barriers and facilitators to smoking cessation/reduction 
and relapse prevention for people in substance misuse treatment/recovery? 
 Do people in substance misuse treatment/recovery or their treatment providers 
perceive smoking cessation/reduction interventions as having an impact on 
substance misuse treatment/recovery and how? 
 When do people in substance misuse treatment/recovery and their treatment 
providers perceive to be the right time for a smoking cessation/reduction 
intervention? 
 What aspects of smoking cessation/reduction interventions for those in 
substance misuse treatment/recovery are perceived to be effective/ineffective 
and why? 
 
2. MATERIALS AND METHODS 
2.1 Inclusion criteria 
2.1.1 Participants 
People in substance misuse treatment or recovery (‘service users’), and those 
involved in providing their substance misuse treatment (‘treatment providers’), in any 
country or setting, of any age were included. We included all forms of substance 
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misuse, including illegal or prescribed drugs, legal highs and alcohol. ‘In treatment’ 
included participants enrolled in inpatient or outpatient treatment programmes. 
Participants were considered ‘in recovery’ if they met the UK Drugs Policy Definition 
of ‘voluntarily sustained control over substance use which maximises health and 
wellbeing and participation in the rights, roles and responsibilities of society’ (27).  
2.1.2 Interventions 
We included studies investigating the effectiveness of smoking cessation/reduction 
interventions where a qualitative evaluation was performed. Non-interventional studies 
evaluating smoking cessation/reduction initiatives for substance misusers, including 
implementation of smoking bans/restrictions, were included.  This was considered 
important as those in treatment or recovery from substance misuse are more likely to 
spend time subject to smoking bans/restrictions than the general population, e.g. 
whilst an inpatient in a treatment centre with a smoking ban, and so this has the 
potential to be a significant barrier or facilitator to smoking cessation for this group. 
We included studies seeking views on smoking cessation of those in substance 
misuse treatment/recovery and treatment providers. 
 
2.1.3 Outcomes 
We included studies reporting on at least one of the following outcomes: 
• Participants’ and treatment providers’ perceptions about barriers and facilitators to 
successful smoking cessation/reduction and/or relapse prevention; 
• Participants’ and providers’ views about whether smoking cessation/reduction 
interventions impact ongoing treatment/recovery from other substance misuse; 
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• Participants’ and providers’ views about if/when smoking cessation/reduction is 
appropriate; 
• Participants’ perceptions about effective/ineffective aspects of smoking 
cessation/reduction interventions. 
2.1.4 Types of study 
 
Qualitative study designs with any recognised method of data collection (e.g. focus 
groups) and analysis from any discipline or theoretical tradition (e.g. 
phenomenological analysis). We included qualitative data reported in interventional 
and mixed methods studies if it was clearly written in the title/abstract that qualitative 
data were sought. 
 
2.2 Search strategy 
  
Following searches from similar systematic reviews (18, 23, 25) a draft search strategy 
was developed in MEDLINE using a combination of MeSH and free text terms. We did 
not specify study types due to poor indexing of qualitative studies (28). This strategy 
was then tested against a previously identified sample of relevant papers. Once 
finalised the search strategy was adapted for other databases. The following 
databases were searched:   
 
• MEDLINE (via Ovid SP) 
• EMBASE (via Ovid SP) 
• Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library) 
• PsychINFO (via EBSCOhost) 
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• Cumulative Index to Nursing and Allied Health Literature (CINAHL) (via EBSCOhost) 
• Applied Social Sciences Index and Abstracts (ASSIA) 
• ProQuest Dissertation and Theses Database 
• Web of Science 
 
We searched from database inception to August 2016. We screened reference lists of 
included studies and systematic reviews identified by our electronic searches. Only 
studies published in English were included. See Box 1 for MEDLINE search strategy.  
 
2.3 Study selection 
 
Search results were merged across databases using Endnote and duplicates 
removed. Titles and abstracts were assessed for eligibility by one author according to 
pre-specified inclusion criteria with 10% of excluded studies double screened by a 
second reviewer. In all cases, the second reviewer concurred. Full texts of studies 
potentially meeting our inclusion criteria were retrieved and assessed for eligibility by 
two independent reviewers. Of 132 full text articles assessed, reviewers disagreed on 
seven. Disagreements were resolved by discussion with a third reviewer. 
 
 
2.4 Assessment of study quality 
 
Study quality was assessed using the Critical Appraisal Skills Programme (CASP) 
Qualitative Research Checklist (29) by one author and checked for accuracy by a 
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second. An aggregate score was calculated for each included study by giving 1 point 
if a criterion was met, 0.5 if partially met, and 0 if not met.  
 
2.5 Data extraction 
 
Data were extracted using a standardised data extraction sheet by one author and 
checked for accuracy by a second. Data extracted included: aims; inclusion/exclusion 
criteria; recruitment method; participant characteristics, including details of substance 
misuse and smoking history where available; data collection method; analysis 
methods; study limitations; and summary of study findings.  
 
2.6 Qualitative synthesis 
 
A thematic content analysis of reported qualitative data was undertaken (30, 31). Data 
were entered into NVivo version 10 to assist with coding. Published qualitative data 
were coded by one reviewer, with a second undertaking independent coding of five of 
the included studies. ‘First-level’ codes aimed to summarise the meaning of the text or 
capture the authors’ original language. Coding was identified as quoted original data 
or author interpretation. Data from service users and treatment providers were coded 
and analysed together, but coding identified whether or not the data were from service 
users or treatment providers. Synthesis involved organisation of first level codes into 
second level descriptive themes, summarising first level codes whilst remaining close 
to the included studies. Third level analytical themes were then developed. This stage 
involved ‘going beyond’ or ‘interpreting’ the first and second level codes to capture the 
line of argument (32) and generate new findings from pooled data. 
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Synthesis worked inductively with the data revealing themes broader than the 
research questions as published in the protocol and described above. To ensure we 
identify relevant data beyond the research questions and do not miss anything that 
might be critical such additional themes were included in the synthesis.  
3. RESULTS 
The screening process identified 21 studies reported in 22 papers (see Figure 1 for 
PRISMA flow diagram (33)). Most were carried out in the USA (n=16) (34-50), with 
two in Australia (51, 52) and one in each of Switzerland, Taiwan and UK (53-55). 11 
studies included only service users (34, 35, 37, 40, 44-46, 50, 51, 54, 55), five only 
treatment providers (41, 42, 47, 48, 52), and five both (36, 38, 39, 43, 49, 53). Results 
of service users and treatment providers are discussed together under the relevant 
analytical theme, with differences in perspectives between them highlighted where 
they were identified. Only one study reported qualitative data on views of a smoking 
cessation intervention (51). The other 20 studies sought views on smoking cessation 
in general, rather than in the context of a specific intervention. A total of nine studies 
reported views of smoking bans/restrictions (39-41, 43-45, 47, 52, 54). Studies were 
of variable quality according to the CASP checklist, with a median combined rating of 
6 out of 10 (range 2-8.5) (see Table 1).   
539 first-level codes were identified, organised into 83 descriptive themes and 
synthesised into the eight analytical themes reported below. The coding diagram 
(Figure 2) illustrates frequency of reporting categories. Sample quotes were chosen 
as best exemplifying each theme. Analytical themes are presented beneath the 
relevant research question.  
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3.1 What are the reported barriers and facilitators to smoking 
cessation/reduction and relapse prevention for people in substance misuse 
treatment/recovery? 
 
Five analytical themes relating to barriers and facilitators to smoking 
cessation/reduction were identified: environmental influences; motivation; mental 
health; smoking bans/restrictions; and relationships with professionals.  
 
3.1.1 Environmental influences 
The influence of other smokers, including service users, staff and relatives, was 
considered by service users and treatment providers to be a key barrier to cessation 
(38, 41, 42, 45, 51, 52, 54). Many reported a strong culture of smoking in substance 
misuse treatment centres, with smoking seen as ‘normal’ (47, 52) and an important 
part of daily routines (38, 40, 52):  
“Instead of saying we’re taking a 5-minute break, the counsellor would be like, 
‘We’re taking a 10-minute smoke break.’ Basically because everybody except 
maybe one person gets up and smokes.” Service user quote (38) 
 
Smoking was considered a way of building relationships to both service users and 
treatment providers (34, 52, 55): 
 
“I’ve been in hostels before and I’ve helped out the hostel by tidying the 
reception area or swept up outside and a member of staff will come outside for 
a cigarette and offer me one for helping” Service user quote (55) 
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Equally, the influence of interested relatives and non-smokers was a facilitator to 
successful cessation for some service users (34, 37, 38, 45, 50, 51), but not all (44): 
“If (your family are) non-smokers like mine are . . . they are like “Hey man, you’re 
doing well”, you know, if they see you’re still not smoking. I had a lot of 
compliments (when I tried to quit smoking).” Service user quote (52) 
 
3.1.2 Motivation 
 
A significant proportion of service users were motivated to quit (34, 37, 38, 44, 49-52, 
55), motivators varied, and factors that motivated some did not motivate others (38). 
‘Higher priorities’, including health, family, children and pregnancy were a key 
motivator (34, 37, 38, 40, 44, 45, 49-52, 55). Cost was a motivator for some (52), but 
not others (38). 
Deficits in knowledge about the harms of smoking was considered a barrier to 
motivation for some, whilst others reported service users had knowledge but were not 
motivated by it (38, 41, 42, 44, 50, 55):  
“I don’t care if it is going to cause me cancer.” Service user quote (38)   
 
Barriers to motivation included enjoyment of smoking (52) and cost of smoking 
cessation products (38, 52).   
3.1.3 Mental Health 
Fear of negative outcomes, including weight gain, insomnia and increased 
alcohol/drug consumption were a key barrier (38, 44, 50, 53). Negative affect (e.g. 
boredom, depression, anxiety, loneliness) was a perceived trigger for smoking and a 
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result of cessation (35, 38, 39, 44-46, 48-51). There was a perception that smoking 
was helpful for stress relief, particularly when there are multiple stressful life 
circumstances, including substance misuse (38, 44, 48, 51), homelessness (55), 
pregnancy (40),  and social disadvantage (52). 
Some service users perceived the addition of smoking cessation to treatment of other 
substances to increase the burden of negative affect to such an extent they felt both 
together was too much (44):  
“It is very difficult to stay focused on why I am here at EH [treatment centre] 
when I want to smoke. I cannot deal with my feelings or express myself because 
I am stressed over wanting a cigarette.” Service user quote (44) 
 
There were some reports of mental health benefits of smoking cessation, including 
hope for the future (51) and feelings of pride (50) and empowerment (40).   
3.1.4 Smoking bans or restrictions 
Smoking bans and restrictions were controversial and perceived to be a facilitator of 
smoking cessation by some service users and treatment providers, and a barrier by 
others.  
Perceived advantages include: reduced smoking (39, 41, 43, 45, 50, 55), ability to 
provide a consistent smoking cessation message (37, 45), health improvements (39, 
44), greater intention/motivation to stop smoking (39), sustained smoking cessation 
after discharge (44, 50), greater awareness of smoking dangers and cessation 
treatments (39), improved physical environment (39), opportunity to experience a 
tobacco and addiction-free life (41, 44), prompted review of tobacco policies (41), 
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improvements in smoking related behaviour problems (42), and allowed service users 
to focus on substance misuse treatment (39).  
The importance of smoking cessation support when a ban/restriction was in place was 
highlighted (37, 39) and smoking bans encouraged discussions about smoking 
cessation (39): 
“It has started more of a discussion with consumers about quitting whereas it 
wasn’t addressed as much before” Treatment provider quote (39) 
 
Despite these advantages significant concerns were expressed, including fears 
service users may avoid centres with smoking restrictions or be evicted if non-
compliant (39, 41, 45, 47).  
Many felt smoking bans were unfair, particularly if similar organisations nearby allowed 
smoking (54), increased feelings of shame (39) and were potentially detrimental to 
recovery (36, 39, 42, 44, 45, 54):  
“All bans have been lifted in prisons throughout Taiwan except here. This is 
way too unfair.’’ Service user quote (54) 
 
Enforcement difficulties (39, 47, 52), reduced service user engagement (39, 47), 
increased irritability (39), smoking outside facilities affecting neighbours (47), danger 
to service users leaving grounds to smoke (47) and fire risk (39) were other 
disadvantages. 
 
Planning in advance of implementation (47), supportive policy environments, such as 
policies requiring organisations to implement similar smoking policies locally, and 
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support from local policy making organisations in the provision of, and access to, 
smoking cessation services, were considered by treatment providers as ways of 
ameliorating these concerns (41, 47): 
 
“My hope is that at some point the state will mandate that all licensed 
programs…have to be non-smoking. Because then we can all do it at the same 
time. Then you don't run into people avoiding your particular treatment center 
because they can't smoke.” Treatment provider quote, (47) 
 
3.1.5 Relationships with professionals 
Supportive staff were perceived by service users as a motivator for smoking cessation 
(45, 50): 
  
“he speaks to you with concern…for him to catch you smoking would be like 
you let him down.” Service user quote (45) 
Some staff felt smoking cessation was important (49, 52):  
“if we’re addressing one substance we need to address all of them. Cigarettes 
kill more than every other drug combined, so I’m seeing it as a necessity.” 
Treatment provider quote (49) 
 
Some service users described lack of support or active discouragement from smoking 
cessation from professionals, despite being motivated (40, 46, 49, 50, 52, 55):  
“When you ask a MD [physician] if you should stop smoking, and they look at 
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your methadone...they act like it’s a joke.” Service user quote (46) 
 
“I had said, ‘You know, I’m just going to quit’. And they told me that they don’t 
recommend that. They don’t recommend you to quit smoking until you have 
been in recovery for a year because it just is stressful and it’s overwhelming.” 
Service user quote (40) 
 
Some treatment providers whose focus was on treating other substance misuse felt 
assisting with smoking cessation was not a priority nor their role (42, 43, 47, 49, 52):  
 
“it's really interesting to have these conversations with addiction specialists, 
where it's like – addiction to nicotine really is seen as something entirely 
different, outside the addiction world…really?...your clients who are trying to get 
recovery tend to use this product a lot, primarily because of their addiction to 
this thing called nicotine!” Treatment provider quote (47)  
 
There were concerns from both service users and treatment providers about the effect 
of staff smoking on service users (42, 47, 49, 52, 54). Some treatment providers felt 
uncomfortable providing smoking cessation advice (42) and many were concerned 
about the effects of such advice, or implementing smoking bans, on the therapeutic 
relationship (39). Some used smoking to build relationships with service users, such 
as giving cigarettes as rewards (55) or allowing patients to flout smoking restrictions 
(42).   
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3.2 Do people in substance misuse treatment/recovery or their treatment 
providers perceive smoking cessation/reduction interventions as having an 
impact on substance misuse treatment/recovery and how? 
 
One analytical theme was identified relating to this question, the relationship between 
smoking and other addictions. Some service users felt this relationship provided a 
rationale for tackling smoking alongside other substance misuse, whilst other service 
users and treatment providers were concerned smoking cessation may have a 
negative impact on substance misuse outcomes, and so the later should be prioritised 
and smoking cessation delayed.  
3.2.1 Relationship between smoking and other addictions 
Smoking and substance misuse were perceived as intimately linked (34, 38, 46, 55). 
How this link affected views on the impact of smoking cessation on substance misuse 
outcomes varied (34, 36, 38, 42, 55), and there were differences between service 
users and treatment providers. Some reported previous experience of a ‘balancing 
effect’ whereby cessation of one substance was associated with increased use of 
another (53), whilst for some, relapse to one was associated with relapse to another 
(37, 38, 44, 55).  
 
Most treatment providers but only some service users felt addictions should be tackled 
one at a time, with substances other than smoking prioritised as they were perceived 
more harmful (38-40, 42, 46, 48, 49, 52, 53). Giving up both together was thought ‘too 
much at once’ and perceived to lead to increased risk of failure (34, 38, 46, 49) or drug 
relapse (34, 38, 40, 47, 48): 
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"We want to get them off of the harsher drugs before we treat them for 
something less severe" Treatment provider quote (48) 
 
Some service users and a minority of treatment providers perceived smoking as part 
of a lifestyle of addiction, and giving up all substances together, as part of a complete 
change of lifestyle, to be effective (34, 38, 44, 50, 53, 55). The idea of being completely 
‘clean’ was identified in three American studies (38, 44, 50):  
“smoking is attached to the drugs…so anything that gives you a chance to 
relapse, a reason to use drugs, should be addressed.” [Unclear from paper 
whether service user or treatment provider] (38) 
“I really want a lifestyle that is free of all drugs and alcohol including cigarettes.” 
Service user quote (44) 
 
The desire to tackle smoking alongside other substances was linked to the perception 
that smoking was like any other addiction (38, 42-44, 46, 47, 49, 51):  
 
‘‘[I was digging] in the trash can and finding cigarette butts and stuff to roll up 
and smoke...it’s hard to explain, but anybody that is familiar with addiction, it 
[smoking] affects you the same way as a drug.’’ Service user quote (46) 
 
However, a number of studies also reported participants often viewed smoking very 
differently from use of other substances (34, 38, 46, 49, 52):  
 
“Cigarettes are legal and you can buy them over-the-counter, whereas all of the 
drugs...are illegal and you can be arrested for having them...and long-term the 
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effects of cigarettes are not immediate as compared to crack...You can have a 
heart attack from smoking crack one time, as compared to cigarettes that cause 
cumulative effects [after] years and years and years of smoking.’’ Service user 
quote (46) 
 
3.3 When do people in substance misuse treatment/recovery and their treatment 
providers perceive to be the right time for a smoking cessation/reduction 
intervention? 
 
Data on perceptions about timing of interventions was limited. As discussed above 
under ‘relationship between smoking and other addictions’ service users had mixed 
views, with some wishing to stop smoking alongside substance misuse treatment and 
others perceiving this to be too much at once and preferring to tackle smoking after 
substance misuse. Treatment providers mostly felt that smoking should come after 
recovery from other substance misuse. However, no more specific views on timing of 
potential interventions were reported. 
  
3.4 What aspects of smoking cessation/reduction interventions for those in 
substance misuse treatment/recovery are perceived to be effective/ineffective 
and why? 
 
To answer this question, characteristics of the interventions perceived to be 
effective/ineffective are considered, followed by aspects relating to intervention 
implementation.  
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3.4.1 Aspects of interventions perceived effective and ineffective 
Different types of interventions were perceived variably, with much overlap. Perceived 
effective interventions were similar among service users and treatment providers and 
included: application of skills learnt in substance misuse treatment to smoking 
cessation (37, 38, 40, 44, 50), pharmacotherapy (38, 41, 43, 50), use of 
incentives/rewards/prizes (41, 43, 45, 47) and smoking cessation champions (42, 47).  
The importance of providing information and education about smoking, cessation and 
treatment options was mentioned multiple times by participants and providers (37, 38, 
41, 43, 44, 51, 53), contrasting with views discussed above that many had good 
knowledge about harms of smoking but were not motivated by this.  
 
Interventions adapted to service user demographics (53) and needs were considered 
effective, including interventions tailored to those in substance misuse treatment (52), 
opportunities to complete a smoking cessation program more than once (51) and 
choice of treatment intensity (41).  
Targeting smoking and substance misuse together was perceived effective by some 
service users and treatment providers (43, 53): 
“he talks sometimes about what different drugs do with nerve receptors and he 
included tobacco in that and what different drugs do with the brain, like how it 
denies oxygen to the brain and that kind of thing.” Service user quote (43) 
Pharmacotherapy was perceived effective by some, whilst others considered it 
ineffective as it targets only the physical addiction and not the habitual aspect (50) and 
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has side effects (40, 44, 51). Some American service users and staff were reluctant to 
use ‘chemical’ help (43, 52):  
“I don’t even understand that [NRT], that’s not even quitting.” Service user quote 
(52) 
Only one study mentioned e-cigarettes, and reported that few treatment providers 
expressed support for their use (47).  
Interventions considered entirely ineffective were aversive therapy (37), going ‘cold 
turkey’ (47, 50), a ‘quit line’ (52) and computer reminders to staff (42).  
3.4.2 Barriers and facilitators to successful intervention implementation 
Change in organisational culture, so smoking is not perceived as normal and is 
routinely addressed, was considered important but challenging (41, 42, 47, 52). 
Importance of strong staff leadership was emphasised by treatment providers (42, 43, 
47). 
Lack of resources was a key issue identified by both service users and treatment 
providers. Cost to patients, lack of programme funding and research funding were 
considered barriers (34, 38, 43, 47, 50, 52): 
 
“All I can say is give the researchers more money until they hit the nail on the 
head”. Service user quote (50) 
 
Treatment providers felt they received insufficient training to feel confident in providing 
smoking cessation support (42, 43, 47):  
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“I wouldn’t have a clue. So maybe it’s just the lack of confidence on my own 
part to maybe help a client choose the right replacement. You know, would I be 
helping…would I be helping them choose the right form of therapy.” Treatment 
provider quote (43)  
 
Some organisations considered smoking cessation as a separate service from 
substance misuse treatment, requiring different training and separate funding (47). 
There were reports of substance misuse treatment programs with no smoking 
cessation treatment provision (43), programs requiring service users to seek treatment 
externally (42) with lack of clear external referral pathways and concerns about stigma 
associated with substance misuse in external services (52), and lack of continuity 
between different services (43, 50).  
 
Barriers could be overcome by reviewing model programs (42), staff training (42), 
leadership support (42), providing appealing tobacco free spaces (47) and free 
treatment (38). 
 
4. DISCUSSION 
This qualitative synthesis summarises available literature on barriers and facilitators 
to smoking cessation among people in substance misuse treatment/recovery, 
perceptions about the effect of smoking cessation on other substance misuse, timing 
of interventions and types of interventions perceived effective.  
Interactions between themes are complex. The perceived intimate link between 
smoking and other substance misuse makes the needs of this population unique. Most 
treatment providers felt giving up multiple addictions together may be too much at once 
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and increased risk of relapse, and generally prioritised cessation of other substances 
over smoking. A mixed-methods systematic review of mental health professionals’ 
attitudes towards smoking cessation among their clients, which included those working 
with substance misusers, although they were not separately analysed, found similar 
results (24). Quantitative findings suggested the most commonly held beliefs among 
professionals were that patients are not interested in smoking cessation and that it 
may be too much to take on alongside mental illness or substance misuse. Qualitative 
thematic synthesis of six studies on mental health professionals attitudes, which 
included two of the studies included in our review relating to substance misuse (42, 
49), identified five key themes: 1) Beliefs about patients quitting smoking; 2) barriers 
to the provision of smoking cessation treatment; 3) attitudes to the provision of 
smoking cessation treatment; 4) acceptance of patients’ smoking; and, 5) smoking as 
a useful tool. Comparing our results to the findings of this study, it seems that attitudes 
of mental health professionals in general regarding smoking cessation among their 
clients are similar to those working specifically in substance misuse. In contrast to the 
views of treatment providers, views of service users were more mixed. Many were 
motivated for smoking cessation, and whilst some perceived that smoking cessation 
alongside substance misuse treatment/recovery may be too much at once, others 
recognised that for them all their addictions are related and contribute to a lifestyle 
they wish to change completely by tackling substances together. This highlights a key 
disparity between perceptions of service users and treatment providers, and our 
results suggest the unique interaction between smoking and other substances makes 
this populations’ needs distinct from the wider mental illness population.  
Qualitative data on perceptions about timing of interventions was limited, but 
suggested there was some appetite for concurrent smoking cessation and substance 
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misuse interventions. Feasibility studies of interventions for dual tobacco and cannabis 
cessation suggest such interventions warrant further investigation through adequately 
powered RCTs (56, 57). A systematic review of smoking cessation interventions for 
substance misusers found four studies of effective concurrent interventions and 
highlighted the need for further research on timing of intervention delivery (18).  
Negative affect was a trigger for smoking and also a perceived result of smoking 
cessation. Some felt dual cessation could lead to greater negative affect. Increased 
negative affect, including feelings of anger, anxiety and depression are inherent to 
nicotine withdrawal in the short term, lasting up to 4 weeks (58). However, a recent 
systematic review suggested these symptoms significantly decrease in the longer 
term, across follow up periods ranging from 7 weeks to 9 years, among those who 
have stopped smoking compared with continuing smokers (59). The perception that 
smoking can help relieve stress was also identified as a barrier to remaining abstinent 
from smoking among pregnant women (60).  
A wide range of interventions were perceived effective and ineffective, with much 
overlap. Perceptions about effectiveness of NRT were mixed, and among those who 
perceived it to be effective, there was no consensus as to preferred route of 
administration, or whether use alone or in combination with other interventions (e.g. 
behavioural support, bupropion) was preferred. A systematic review of 17 studies by 
Thurgood et al. identified five studies reporting significant effects on smoking cessation 
for interventions using NRT, behavioural support, and a combination of these (18). 
Baca et al. suggest that as smokers who also misuse other substances are often highly 
dependent on nicotine, pharmacotherapy may be more important than for the wider 
population (9). Our results, combined with the results of these reviews, suggest 
perhaps a range of interventions should be offered, including pharmacotherapy, 
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behavioural interventions and combination interventions, with options for dual smoking 
and substance misuse treatment or separate interventions available at different time 
points as per the users’ needs, and with options to move in and out of smoking 
cessation treatment. This also fits with emerging evidence that among the general 
population most smokers make multiple quit attempts and new quit attempts often 
occur within a few days of relapse (61).  
Some felt smoking bans were effective, whilst others considered them to have a 
negative impact on substance misuse treatment. The conflicting views are similar to 
those in the literature on smoking restrictions in psychiatric hospitals (62) and prisons 
(63). There is a need for changing models of organisations to ensure where smoking 
restrictions are in place, cessation therapy is widely available and quickly accessible 
at the point of need. 
There were examples of enthusiastic treatment providers greatly appreciated by 
service users, but many more of motivated services users feeling they lacked support 
from professionals. Unlike most of the general population, those in treatment or 
recovery from substance misuse may have very close, long-term relationships with 
professionals as a result of participating in intensive treatment and supported 
recovery, and so such professionals have a unique opportunity to encourage and 
facilitate smoking cessation if given the support to do so by their organisation. Most of 
the treatment providers in the included studies appeared not to be trained in smoking 
cessation. Most treatment providers prioritised other substance misuse outcomes, 
which was the focus of their service, over wider health gains for individual substance 
misusers. Reluctance to provide lifestyle advice is not unique to this group. A 
qualitative study of pharmacists identified reluctance to provide advice on weight, diet 
and alcohol use for fear of negative patient response (64). Training for treatment 
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providers on giving lifestyle advice is needed. The UK initiative ‘Making Every Contact 
Count (MECC)’ encourages conversations based on behaviour change methodologies 
to empower healthier lifestyle choices, including smoking cessation, making every 
health and social care contact an opportunity for health promotion (65).  
A number of possible theoretical frameworks could be used in the development of 
interventions for service users and treatment providers. The Transtheoretical Stages 
of Change Model (66) suggests there are stages on the continuum of behaviour 
change, which are pre-contemplation, contemplation, preparation, action and 
maintenance. Individuals in the same stage of change are suggested to have similar 
barriers and facilitators to success and so thought to benefit from similar interventions. 
Motivational Interviewing (MI) may have a role to play as a brief, patient-centred, 
learnable set of communication skills that treatment providers could use to support 
service users to stop smoking, which is non-judgemental and based on compassion, 
respect and empathy (67). However, neither fully captures the social, economic and 
environmental factors affecting behaviour, nor specifically discusses the common 
aetiology of dual substance misuse, which the results of this review suggest may be 
key.  
The PRIME (plans, responses, impulses, motives and evaluations) Theory of 
motivation may be the most appropriate theory on which to base a smoking cessation 
intervention for substance misusers in light of the results of this review (68). This 
suggests addiction can be usefully viewed as a disorder of the ‘motivational system’, 
which may include underlying abnormalities of this system which are: independent of 
the addictive behaviour (e.g. propensity to anxiety or depression or a motivational 
system that already lacks balance); stem from the addictive behaviour itself by 
undermining normal checks and balances (e.g. habit); and an unbalanced 
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environment (e.g. social pressures to engage in the activity). The theme identified in 
this qualitative synthesis regarding the relationship between smoking and other 
substance misuse integrates with the theory of disordered motivation, and the other 
analytical themes identified in the synthesis can be matched to abnormalities of the 
‘motivational system’ independent of the addictive behaviour (mental health), those 
stemming from the addictive behaviour (habit, discussed under aspects of 
interventions perceived effective and ineffective) and those stemming from the 
environment (environmental influences; smoking bans/restrictions; relationships with 
professionals). Aspects of interventions perceived to be effective could be seen to be 
targeting each of these areas of disordered motivation.  
 
This review has several limitations. Only one study using qualitative methods in the 
evaluation of a smoking cessation intervention was found. The other 20 studies sought 
views on smoking cessation in general, rather than in the context of a specific 
intervention. There is a lack of qualitative process evaluations performed alongside 
trials of smoking cessation interventions for substance misusers. The majority of the 
included studies were performed in the USA, and none of the studies were performed 
in low or middle income countries. Overall methodological quality was moderate. The 
CASP checklist was used to give an indication of study quality, and indicative scores 
were given to each study based on the number of criteria met by the study. However, 
the checklist was not originally designed to be used in this way, and the scores are for 
the purposes of discussion and reflection rather than a true quantitative measure of 
quality.  
5. CONCLUSIONS 
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Too little is being done to address the high prevalence of smoking amongst those in 
treatment or recovery from other substance misuse. High smoking prevalence, strong 
relationships between smoking and substance misuse and opportunities for 
intervention whilst in treatment make this population unique. In view of the 
considerable morbidity and greater risk of mortality among substance misusers who 
also smoke, it is important to consider ways to address the identified barriers. Indeed, 
in the UK context where health care professionals should be ‘making every contact 
count’, there is a duty of care to take a holistic approach attending to wider lifestyle 
behaviours, including smoking cessation, which are likely to have the biggest long term 
impact on health. Treatment providers need additional training and resources to be 
able to provide support for smoking cessation. More research is required to build on 
the limited evidence base to develop enhanced packages of care tailored toward this 
deprived group of smokers.  
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Figure 1. PRISMA flow diagram 
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12012 records after duplicates removed 
12012 records screened 11880 records excluded 
132 full text articles assessed for eligibility 
110 full text articles excluded 
21 studies (in 22 papers) included in 
qualitative synthesis 
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Figure 2. Qualitative synthesis coding overview 
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Box 1. Search strategy as used in MEDLINE 
Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid 
MEDLINE(R) 1946 to Present 
1 Substance-Related Disorders/         
2 exp Alcohol-Related Disorders/        
3 Amphetamine-Related Disorders/        
4 Cocaine-Related Disorders/         
5 Inhalant Abuse/          
6 Marijuana Abuse/          
7 exp Opioid-Related Disorders/         
8 Phencyclidine Abuse/          
9 Substance Abuse, Intravenous/        
10 exp Alcohol Drinking/          
11 Marijuana Smoking/          
12 Methadone/           
13 exp Substance Abuse Treatment Centers/       
14 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13   
  
15 exp Smoking Cessation/          
16 exp “Tobacco Use Cessation”/        
17 exp “Tobacco Use Cessation Products”/       
18 ((smok* or tobacco) adj4 (quit* or stop* giv* or ceas* or cessation or 
 abstain or abstinen*)).ti,ab.       
  
19 ((smok* or tobacco) adj4 (reduce OR reduction OR reducing OR reduces OR  
gradual OR gradually OR decline OR declines OR decrease OR  
(cut* AND down))).ti,ab.        
40 
 
20 (smoke-free or smoke free or smokefree).ti,ab.       
21 (tobacco-free or tobacco free or tobaccofree).ti,ab.      
22 15 or 16 or 17 or 18 or 19 or 20 or 21        
24 14 and 22 
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Table 1 Study characteristics 
Lead author, 
publication 
year, reference 
Aim/focus, study design and 
analysis 
Country where 
study was 
conducted 
Participant description and 
demographics (including if 
in treatment or recovery or 
both, substances used, 
duration of substance 
misuse, cigarettes smoked 
per day in pack years) 
Summarised findings and conclusions Quality 
rating 
Ambrose 2012 Aims: ‘to 1) contextually explore 
the relationship between 
cigarette smoking and injection 
drug use, 2) identify facilitators 
and barriers of smoking 
cessation among recovering 
injection drug users, and 3) 
explore perceptions of nicotine 
replacement therapy (NRT) as 
an aid to quit smoking.’ 
 
Study design: focus groups 
 
Analysis: thematic analysis 
USA 
 
Single centre 
30 service users in treatment 
and recovery (30% had 
recently been treated for 
alcohol or drug abuse) 
 
50% female 
93% African American 
Median age 44, IQR 47-54 
80% current daily smokers 
33% actively injecting drugs 
37% crack use 
60% alcohol use 
20% living with HIV 
Previous cessation attempts had reduced 
tobacco exposure among people with a 
history of injection drug use. “Denormalising” 
smoking in substance misuse treatment and 
teaching methods for dealing with cravings 
recommended. Further research required to 
develop models of smoking cessation 
services integrated with treatment for 
substance misuse and to identify predictors of 
success for service users successfully quitting 
smoking and other substances together or via 
a stepped approach.  
5.5 
Asher 2003 Aims: ‘to report the relative 
frequency of endorsement of 
the various barriers as a source 
of guidance for clinicians 
wanting to motivate alcoholic 
patients to quit smoking, and to 
provide a replication on a 
second set of substance 
abusers of general barriers and 
an extension of previous 
research by asking about 
sobriety-specific barriers. 
 
Study design: one open ended 
survey item 
USA 
 
Single centre 
96 alcohol dependent service 
users in residential treatment 
completed a quantitative 
survey, 52 answered the one 
open ended question 
 
82% Caucasian, 15%, African 
American, 3% Other. 
59% male 
Mean age 35.4 years (SD = 
7.6) 
According to coded responses to the one 
open ended survey item, barriers to smoking 
cessation included negative affect, habitual 
aspects of smoking, seeing others smoke, 
addiction to multiple substances, compulsion 
and mental urges.  
4 
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Lead author, 
publication 
year, reference 
Aim/focus, study design and 
analysis 
Country where 
study was 
conducted 
Participant description and 
demographics (including if 
in treatment or recovery or 
both, substances used, 
duration of substance 
misuse, cigarettes smoked 
per day in pack years) 
Summarised findings and conclusions Quality 
rating 
 
Analysis method: two people 
independently coded the 
responses and grouped them 
into categories based on similar 
content 
Becker 2013 Aims: ‘addiction experts 
participated in the semi-
structured interviews about the 
relationship between tobacco 
and cannabis use and the 
demand for and possible design 
of an ISCP' (integrative 
smoking cessation program).  
 
'focus group discussions were 
conducted to gain indepth 
information concerning users’ 
problems, experiences, and 
methods of coping with the 
issues that occurred during 
cessation attempts.' 
 
Study design: Semi-structured 
interviews with addiction 
experts and focus groups with 
service users 
Analysis: Not specified 
Switzerland 
 
Single centre 
14 past/current tobacco 
smokers who also use or 
have used cannabis several 
times per week and are 
accessing a counselling 
service and 12 addiction 
experts 
 
Service users included 10 
adolescents aged 16 to 22 
years and four adults aged 27 
to 39 years 
 
Expert interviews - relationship between 
tobacco and cannabis use can impact 
cessation attempts. Those using both may 
increase use of the other when attempting to 
stop one of the substances. Quitting both 
simultaneously might prevent this balancing 
effect, but co-smokers may struggle to give up 
both together.  
 
Participant focus groups - reported 
experiencing the balancing effect. Willingness 
to quit both substances together low, but an 
intervention targeting both may be useful 
because of the strong relationship between 
the substances.  
4.5 
Bobo 1986 Aims: ‘summarize findings 
reported to date on smoking 
among alcoholic populations 
and then detail the experiences 
USA 
 
14 adult service users in 
recovery following graduation 
from an intensive alcohol 
treatment program who had 
Those recovering from alcohol misuse can 
successfully stop smoking whilst maintaining 
abstinence from alcohol.  
 
3 
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Lead author, 
publication 
year, reference 
Aim/focus, study design and 
analysis 
Country where 
study was 
conducted 
Participant description and 
demographics (including if 
in treatment or recovery or 
both, substances used, 
duration of substance 
misuse, cigarettes smoked 
per day in pack years) 
Summarised findings and conclusions Quality 
rating 
of 14 recovering alcoholics who 
successfully quit smoking.’ 
 
Study design: Telephone 
interviews 
 
Analysis: Summary data 
presented 
Unclear if 
single/multicentr
e 
successfully stopped smoking 
for at least 6 months 
 
100% Male 
93% Caucasian 
Mean age 40 (range 29 to 64) 
Bobo 1993 Aims: 'This paper summarizes 
our findings on the tobacco use 
experiences of a sample of 124 
CDU [chemical dependency 
unit] counselors in Nebraska 
who identified themselves as 
recovering alcoholics or 
problem drinkers.' 
 
 
Study design: Free text space 
for comments at the end of a 
questionnaire 
 
Analysis: Not specified 
USA 
 
Treatment 
providers in 34 
chemical 
dependency unit 
study 
approached for 
participation 
125 chemical dependency 
unit staff with a personal 
history of alcoholism or 
problem drinking, 80% (n=99) 
with a smoking history 
 
80% White and non-Hispanic, 
16% Native American, 4% 
either Hispanic or Asian 
43% female 
10% were between the  
ages of 20 and 29; 36% were 
between 30 and 39; 30% 
between 40 and 49; and 24% 
were over 50. 
Some reported service users should not be 
pressured into smoking cessation, although 
one participant supported a smoking ban. 
Some participants felt service users may 
benefit from provision of information about 
health effects. There were reports of 
successful smoking cessation, and others 
who remained determined to continue 
smoking. Some felt cessation alongside 
substance misuse treatment was a big 
challenge, and both together may be too much 
at once.   
  
 
2 
Chang 2010 Aims: 'to understand smoking 
behavior, the needs for smoking 
cessation, and the perceptions 
of the implementation of 
smoking bans among drug 
abusers in a prison in Taiwan.' 
 
Study design: Focus groups 
 
Taiwan 
 
Single centre 
77 service users in a prison-
based substance misuse 
treatment centre 
 
100% Male 
Average age was 37 years 
(SD 8.1). 
Before entering the prison 
42.9%s used heroin or 
Unintended consequences occurred when a 
smoking ban was implemented at this prison-
based substance misuse treatment centre in 
Taiwan. Service users felt the policy was 
hypocritical, encouraged a black market in 
tobacco and that there was a lack of support 
and treatment for those wanting to stop 
smoking.   
 
6.5 
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Lead author, 
publication 
year, reference 
Aim/focus, study design and 
analysis 
Country where 
study was 
conducted 
Participant description and 
demographics (including if 
in treatment or recovery or 
both, substances used, 
duration of substance 
misuse, cigarettes smoked 
per day in pack years) 
Summarised findings and conclusions Quality 
rating 
Analysis: Content analysis morphine only, 40.3% used 
heroin or morphine combined 
with amphetamines and 
16.8% used only 
amphetamines.  
 
Cooperman 
2015 
Aims: ‘To develop an 
Information-Motivation-
Behavioral Skills (IMB) Model of 
behavior change based 
smoking cessation intervention 
for methadone maintained 
smokers, we examined 
smoking cessation related IMB 
factors in this population.’  
 
Study design: Focus groups 
with service users and 
individual interviews with 
treatment providers.  
 
Analysis: Content analysis 
using deductive and inductive 
approaches.  
USA 
 
Two urban 
methadone 
clinics 
35 service users and 10 
treatment providers in 
methadone maintenance 
clinics 
 
Service users: 65% White, 
29% Black, 9% Hispanic 
Treatment providers: 70% 
White, 20% Hispanic, 20% 
Black 
Service users: 54% female 
Treatment providers: 70% 
female 
Service users: median age 46 
(IQR 39-51) 
Treatment providers: median 
age 46 (IQR 35-58) 
Smokers on methadone may benefit from 
further research into a IBM model based 
smoking cessation intervention that is 
individualised and addresses IBM factors 
common among all smokers and those 
specific to this population.  
8.5 
Eby 2012 Aims:  'explores counselors’ 
and clinical supervisors’ 
perceptions of the [smokefree] 
regulation by content analyzing 
responses to open-ended 
questions asking about the 
positive and negative effects of 
the regulation approximately 1 
year after its official passage.'  
USA 
 
50 freestanding 
substance 
abuse treatment 
centres affiliated 
with 16 
treatment 
organizations 
261 substance abuse 
treatment counsellors and 80 
clinical supervisors working in 
treatment centres/affiliated 
organisations in New York 
State.  
 
Treatment provider’s views of smoking bans 
within substance misuse treatment centres 
were mixed. The most commonly cited 
advantages was positive behaviour change, 
and development of ‘addict behaviours’ the 
most frequently reported negative.   
 
 
 
7 
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Lead author, 
publication 
year, reference 
Aim/focus, study design and 
analysis 
Country where 
study was 
conducted 
Participant description and 
demographics (including if 
in treatment or recovery or 
both, substances used, 
duration of substance 
misuse, cigarettes smoked 
per day in pack years) 
Summarised findings and conclusions Quality 
rating 
 
 
Study design: Two open ended 
survey items 
 
Analysis: Inductive content 
analysis using grounded theory 
to categorise responses of the 
two open ended survey items 
separately for service users and 
treatment providers.  
 
 
throughout New 
York State 
60%/70% of 
counsellors/clinical 
supervisors Caucasian 
61%/58% of 
counsellors/clinical 
supervisors female 
Average age 44 (SD 13.5 
years)/48 (SD 11.71) for 
counsellors/clinical 
supervisors.  
The most frequently reported 
substances used among 
patients seeking treatment 
were alcohol (39%), 
marijuana (29%), cocaine 
(27%), and heroin (27%). 
 
Fallin 2016 Aims: ‘to describe: 
(1) facilitators and barriers to 
engaging in tobacco treatment 
among 
pregnant, opioid dependent 
women receiving MAT 
[medication assisted 
treatment]; and (2) strategies to 
tailor tobacco treatment 
interventions with this 
population.’ 
 
Study design: Semi-structured 
focus groups 
 
Southern USA 
 
Single centre 
22 service users receiving 
MAT during pregnancy and 
up to 6 weeks post-partum. 
Mean age 28 (range 22-37) 
with ‘no racial or ethnic 
diversity.’ 
Participants motivated to stop smoking but 
faced multiple barriers. Authors suggest 
integrating smoking cessation and MAT to 
allow for the provision of tailored treatment in 
a supportive environment.  
6.5 
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Lead author, 
publication 
year, reference 
Aim/focus, study design and 
analysis 
Country where 
study was 
conducted 
Participant description and 
demographics (including if 
in treatment or recovery or 
both, substances used, 
duration of substance 
misuse, cigarettes smoked 
per day in pack years) 
Summarised findings and conclusions Quality 
rating 
Analysis: Codebook developed 
prior to data analysis based on 
researcher team experience of 
focus groups and literature. 
Transcripts coded to 
consensus, codes then 
examined to identify themes 
and patterns.  
Foulds 2006 Aims: ‘This paper aims to 
summarize the lessons learned 
from the experience in New 
Jersey.’ [the first state to require 
all residential substance misuse 
treatment programmes have 
smoke free grounds].   
 
Study design: Qualitative 
feedback survey 
 
Analysis: Not specified.  
USA 
 
30 centres 
Executive and clinical 
directors of 30 New Jersey 
residential programs – exact 
sample size not specified 
Treating tobacco in substance misuse 
treatment considered valuable by treatment 
providers, but they were concerned about the 
effect of inconsistent smoking restriction 
polices, which was perceived to risk reduced 
admissions and revenues for smoke free 
centres. Importance of staff training, 
developing treatment services prior to 
implementing smoking restrictions, and 
integration of inpatient and outpatient 
treatment were emphasised.    
 
2 
Garner 2013 Aims: ‘to explore homeless 
smokers’ views, attitudes, 
experiences and knowledge 
with regard to smoking and 
quitting in an urban UK setting.’ 
 
Study design: Semi-structured 
face-to-face interviews 
conducted with homeless 
smokers in Nottingham, UK. 
 
UK 
 
Single centre 
15 homeless smokers 
addicted to drugs or alcohol 
accessing a community harm 
reduction service 
 
27% female 
Mean 33, range 18-53 
53% alcohol, 40% cannabis, 
27% heroin, 27% crack, 20% 
amphetamine 
40% methadone currently on 
The homeless substance misusing population 
accessing a drug harm reduction service 
included in the study were confident they 
could quit smoking if they wanted to and some 
were motivated to do so, but in the past they 
had rarely been offered support for smoking 
cessation and sometimes received active 
discouragement, so an opportunity to offer 
smoking cessation support to this vulnerable 
group is potentially being missed. 
6.5 
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Lead author, 
publication 
year, reference 
Aim/focus, study design and 
analysis 
Country where 
study was 
conducted 
Participant description and 
demographics (including if 
in treatment or recovery or 
both, substances used, 
duration of substance 
misuse, cigarettes smoked 
per day in pack years) 
Summarised findings and conclusions Quality 
rating 
 
Analysis: framework analysis.   
60% in treatment for 
drug/alcohol misuse 
Gifford 2015 Aims: 'this qualitative study 
examined how SC [smoking 
cessation] treatment is 
delivered in VHA [Veteran 
Health Association] substance 
use disorder residential 
treatment programs (SRTPs) 
and the barriers and 
opportunities for growth that 
exist within these settings.' 
 
Study design: Semi-structured 
interviews 
 
Analysis: Content analysis.  
USA 
 
15 study sites 
25 treatment providers across 
15 study sites directly 
involved in or knowledgeable 
about smoking cessation 
implementation efforts 
 
Of licensed participants 75% 
were Caucasian, 17% 
preferred not to say, 8% were 
other and 0% answered 
African American. Of not 
licensed participants 62% 
were Caucasian,  15% 
African  American, 15% prefer 
not to say and 8% other 
56% female 
There were considerable barriers to 
implementing smoking cessation treatment, 
including lack of local leadership and poor 
enforcement of local and national policies 
undermining accountability and uptake. There 
was evidence of inadequate knowledge and 
experience among staff, perpetuating 
ambivalence to the provision of smoking 
cessation treatment.  
6 
Hunt 2012 
Richter 2012 
Aims: ‘to obtain descriptions of 
tobacco treatment services 
across different substance 
abuse treatment settings’ (43) 
and ‘identify subjective 
experiences and social 
processes that may inﬂuence 
facility adoption of tobacco 
treatment policies and 
practices’ (49). 
 
Study design: qualitative 
interviews conducted until 
theoretical saturation reached.  
USA 
 
8 facilities 
8 clinical directors, 25 staff 
and 29 service users in 
treatment in outpatient 
substance misuse facilities 
 
69% of directors and staff 
White, 91% non-Hispanic. 
69% of service users white 
and 96% non-Hispanic.  
69% of directors/staff and 
45% of service users female 
69% of clients were <45 and 
76% were 18-35 on entering 
treatment.  
Service users often had to specifically request 
treatment and few staff reported encouraging 
unmotivated smokers to quit. There were no 
systems to facilitate consistent, evidence-
based smoking cessation treatment.  
8 
48 
 
Lead author, 
publication 
year, reference 
Aim/focus, study design and 
analysis 
Country where 
study was 
conducted 
Participant description and 
demographics (including if 
in treatment or recovery or 
both, substances used, 
duration of substance 
misuse, cigarettes smoked 
per day in pack years) 
Summarised findings and conclusions Quality 
rating 
 
Analysis: Content analysis.  
Jones 2007 Aims: ‘How are women in 
treatment for chemical 
dependency whose children are 
with them affected by the ban of 
the use of tobacco products in 
the treatment facility?’ 
 
Study design: Interviews and 
focus groups and a survey with 
some open ended questions  
 
 
Analysis:  Surveys analysed 
using SPSS. Focus groups and 
interviews hand transcribed as 
author felt participants may not 
wish to be recoded. Transcripts 
reviewed for repetitious words, 
phrased and sentiments, 
organised into themes and 
categories of themes.  
USA 
 
Single centre 
13-20 service users in a 
halfway house for chemically 
dependent women whose 
children reside with them in 
the treatment facility, who 
have been in treatment for at 
least 30 days (7 service users 
interviewed, 13 participated in 
focus groups, unclear if 
overlap of participants) 
 
Interviews: 3 Caucasian, 3 
African American, 1 Cuban 
Focus group: 3 Caucasian, 4 
Black, 1 Native American, 1 
Hispanic 
100% female 
Interviews: mean age 31.7 
(6.7) 
Not reported for focus groups 
Participants were motivated to remain tobacco 
free, but felt that the smoking ban affected 
their substance misuse treatment.  
 
 
5.5 
Ker 1996 Aims:’ examines the issues 
around involuntary smoking 
cessation (ISC) and women in 
substance abuse treatment.’  
 
Study design: Two focus groups 
with service users 
 
USA 
 
Single centre 
34 service users at a 
residential substance misuse 
treatment program where 
mothers stay with their 
children and where smoking 
is banned 
 
A properly designed smoking ban can be 
instituted at a residential substance misuse 
treatment centre for women without excessive 
program disruption and with positive results. 
5.5 
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Lead author, 
publication 
year, reference 
Aim/focus, study design and 
analysis 
Country where 
study was 
conducted 
Participant description and 
demographics (including if 
in treatment or recovery or 
both, substances used, 
duration of substance 
misuse, cigarettes smoked 
per day in pack years) 
Summarised findings and conclusions Quality 
rating 
Analysis: Transcripts ‘analysed 
and coded’ by one author, 
checked for accuracy and 
validity by a second author.   
21% Mexican America, 64% 
European American, 14% 
African American 
100% female 
Mean age 30.8 
McCool 2003 Aims: ‘examined patients’ 
observations of what is unique 
about methadone and other 
drugs that led the vast majority 
to smoke. Identifying the 
contexts and consequences of 
patient smoking may help us to 
develop more successful 
interventions in this population 
devastated by tobacco-related 
morbidity and mortality.’ 
 
Study design: Focus groups 
and individual interviews 
 
Analysis: Focus groups and 
interviews audiotaped and 
professionally transcribed. 
Transcriptions compared with 
audiotapes by authors and 
discrepancies corrected. Focus 
group and interview recordings 
by each participant were 
matched.  
USA 
 
5 methadone 
maintenance 
treatment 
centres 
59 service users receiving 
methadone maintenance 
treatment continuously for at 
least 2 years 
 
78% white 
58% female 
Mean age 44 years 
Mean duration of methadone 
maintenance 11 years 
 
Most patients linked smoking, methadone, 
and drug use, reporting they were 
complementary and shared similar cues and 
withdrawal symptoms. They reported that 
smoking differed from other substance misuse 
as it had fewer acute consequences. Due to 
the relationships between smoking and 
substance misuse future interventions should 
consider addressing them in combination.  
8 
Mikahilovich 
2008 
Aims: qualitative data provided 
rich accounts of peoples’ 
Australia 
 
Single centre 
6 service users from a 
residential drug and alcohol 
rehabilitation service, who 
Interventions involving NRT for special 
populations, including those in residential drug 
and alcohol rehabilitation, requires a more 
6.5 
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Lead author, 
publication 
year, reference 
Aim/focus, study design and 
analysis 
Country where 
study was 
conducted 
Participant description and 
demographics (including if 
in treatment or recovery or 
both, substances used, 
duration of substance 
misuse, cigarettes smoked 
per day in pack years) 
Summarised findings and conclusions Quality 
rating 
experiences in the [smoking 
cessation] program.’   
 
Study design: Narrative 
interviews with service users 
 
Analysis: Not specified.  
had been through a 
detoxification programme, 
resident with their children, 
who had participated in a 
smoking cessation 
programme 
 
intensive, customised approach, delivered by 
appropriately trained staff.  
 
 
 
Pagano 2016 Aims: 'The present study 
examines facilitators of, and 
barriers to, tobacco use policies 
and tobacco cessation services 
as reported by directors from a 
nationwide sample of addiction 
treatment programs 
participating 
in the NIDA Clinical Trials 
Network (CTN).' 
 
Study design: semi-structured 
telephone interviews 
 
Analysis: thematic analysis 
USA 
 
8 outpatient, 9 
residential and 7 
methadone 
programmes 
 
24 programme directors  
 
83.3% White, 8.3% Native 
American, 4.2% African 
American, 4.2% Hispanic 
58.3% female 
Mean age 51 (SD 10.9) 
Of the directors themselves 
9.1% were in recovery from 
substance misuse and 17.4% 
were current smokers. 
Substance misuse treatment programs are 
starting to place greater emphasis on smoking 
cessation but substantial infrastructural and 
cultural change is still needed.  
 
 
7 
Richter 2002 Aims: ‘(a) to identify ways to 
tailor nicotine dependence 
treatment to patients, and (b) to 
assess whether smoking 
reduction and nicotine 
maintenance are attractive and 
potentially harm-reducing 
options for people who do not 
consider quitting an option.’ 
 
USA 
 
5 methadone 
maintenance 
treatment clinics 
78 service users enrolled 
continuously in methadone 
maintenance for last 2 years  
 
78.2% White 
57.5% female 
Mean age 43.6 years 
Average of 10.8 years in 
methadone maintenance 
treatment 
Successful quitters generally used a 
combination of methods. Nicotine craving was 
cited as the biggest challenge to staying 
stopped, but NRT was favoured by only a few 
participants with major health problems who 
thought a quit attempt would be unlikely to 
succeed.  
Some feared quitting smoking would divert 
them from their goal of quitting substance 
misuse, but others felt the skills they had 
4.5 
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Lead author, 
publication 
year, reference 
Aim/focus, study design and 
analysis 
Country where 
study was 
conducted 
Participant description and 
demographics (including if 
in treatment or recovery or 
both, substances used, 
duration of substance 
misuse, cigarettes smoked 
per day in pack years) 
Summarised findings and conclusions Quality 
rating 
Study design: Focus groups 
and interviews 
 
Analysis: Demographic data 
analysed using SPSS. 
Interviews and focus groups 
audiotaped and coded using 
QSR Nudist IV. Inter-rate 
reliability for 24 key codes 83% 
agreement (kappa score of 0.57 
which is ‘fair’).   
Continuous smokers, 
relapses and successful 
quitters from  
learnt in substance misuse treatment could be 
successfully applied to smoking cessation.  
 
Smokers were interested in smoking reduction 
as an alternative to quitting; but those who had 
failed to reduce smoking preferred complete 
cessation.  
Richter 2006 Aims: ‘presents qualitative and 
quantitative information on 
provider attitudes regarding 
tobacco treatment in drug 
treatment.' 
 
Study design: Survey including 
open ended questions 
 
Analysis: Responses to open 
ended questions transcribed in 
Microsoft Excel, examined for 
common terms and comments 
categorised as to whether or not 
each common theme applied to 
them. Quotes exemplifying 
each theme were displayed in 
an illustrative table.  
USA 
 
408 clinics 
408 treatment providers 
(medical directors, clinic 
directors, head nurses and 
supervising counsellors) from 
clinics providing methadone 
maintenance.  
 
 
Many treatment providers felt treatment of 
other substance misuse was more important 
than smoking cessation, and that patients 
should not change too many things at the 
same time. They felt that smoking cessation 
may not be appropriate when service users 
were new to treatment, experiencing stress, 
reducing methadone dose or undergoing a 
detox. Some felt smoking was beneficial for 
managing negative affect and as a substitute 
for other drug use. 
 
 
4 
Wilson 2015 Aim: ‘to explore service users 
and treatment providers’ 
experiences, attitudes and 
Australia 
 
10 treatment providers from 4 
programs 60% female Mean 
age 52 Age range 32-65 
Both service users and treatment providers 
would like more to be done about smoking in 
substance misuse treatment. Staff reported 
7.5 
52 
 
Lead author, 
publication 
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Aim/focus, study design and 
analysis 
Country where 
study was 
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in treatment or recovery or 
both, substances used, 
duration of substance 
misuse, cigarettes smoked 
per day in pack years) 
Summarised findings and conclusions Quality 
rating 
beliefs about smoking cessation 
in substance misuse treatment 
settings.’ 
 
Study design: Semi-structured 
interviews with treatment 
providers and focus groups with 
clients 
 
Analysis: Data were transcribed 
and analysed using constant 
comparative analysis, an 
inductive method.  
4 government 
funded 
treatment 
programs (a 
community 
based opiate 
treatment 
program, an 
inpatient and an 
outpatient 
hospital based 
service and a 
detoxification 
unit).  
  
2 current smokers.  
 
11 service users 
9% female Mean age 34 
Age range 24-53 
All current smokers. 
barriers, including lack of time, organisational 
culture, lack of enforcement of smoking 
restrictions, belief that it is not a priority, belief 
that smoking helps service users cope with 
substance misuse treatment, and perceptions 
that smoking cessation is ineffective or not 
used. Service users reported smoking due to 
habit, enjoyment, for stress relief, after seeing 
staff smoking, due to cost of NRT and 
concerns about NRTs addictiveness.  
 
 
